COST EVALUATION OF STROKE THERAPY COMPARED TO INA-CBGs ON INPATIENTS AT ANUTAPURA HOSPITAL
Downloads
ABSTRACT
Stroke is the third cause of death in the world after heart disease, cancer, and disability including disability categorized based on its severity: mild (I), moderate (II), and severe (III) severity. This study aims to determine the difference total cost of ischemic and hemorrhagic stroke therapy, each, with INA-CBGs rates. The method of data collection was conducted retrospectively taken from medical record data, and on patient medical expenses. The subject were ischemic and hemorrhagic stroke patients hospitalized from 2016-2017 at Anutapura Hospital who met the inclusion and exclusion criteria. There were 134 patients who met the inclusion criteria, 68% were ischemic stroke patients and 32% were hemorrhagic stroke patients. The result of research showed that there were significant differences in costs (p <0.05) between hospital real costs and INA-CBGs rates. The average total real cost of treatment for ischemic stroke therapy was IDR 7,360,196.70 and the cost of the INA-CBGs was IDR 7,427,251.65 for 91 inpatients; and the average total cost of patients with hemorrhagic stroke therapy took IDR 10,606,834.34 with average of INA CBG's rate at IDR 4,399,393.02 for 43 inpatients. The conclusion is both of stroke therapy proved significant difference compared to BPJS claimed amount of money.
Keywords: pharmacoeconomic, cost analysis, ischemic stroke, haemorrhage stroke, INA-CBG's rate.
Armalina, D., Witjahjo, B., Susilaningsih, N., Purnawati, R. D., Ismail, A., & Saktini, F. (2020). Screening for Hypertension and Electrocardiography (ECG) for Cardiovascular Diseases Risk. Kemas: Jurnal Kesehatan Masyarakat, 15(3), 303–308. https://doi.org/https://doi.org/10.15294/kemas.v15i3.17969.
Baroroh, F., & Fauzi, L. A. (2017). Analisis Biaya Terapi Stroke pada Pasien Rawat Inap di Rumah Sakit PKU Muhammadiyah Bantul Yogyakarta. Jurnal Ilmiah Ibnu Sina, 2(1), 93–101. https://doi.org/https://doi.org/10.36387/jiis.v2i1.87.
Budijanto, D., Kurniawan, R., Widiantini, W., Aprianda, R., Mulya, D., Suryani, E., & Indrawtai, L. (2019). No Title. Kementerian Kesehatan RI.
Dourman, K. (2013). Waspadai Stroke Usia Muda. Cerdas Sehat.
Powers, W. J., Derdeyn, C. P., Biller, J., Coffey, C. S., Hoh, B. L., Jauch, E. C., Johnston, K. C., Johnston, S. C., Khalessi, A. A., Kidwell, C. S., Meschia, J. F., Ovbiagele, B., & Yavagal, D. R. (2015). No Title. Stroke: A Journal of Cerebral Circulation, 46(10), 3020–3035. https://doi.org/https://doi.org/10.1161/STR.0000000000000074.
Sofiana, L., & Rahmawati, D. D. (2019). Hypertension and Diabetes Mellitus Increase the Risk of Stroke. Kemas: Jurnal Kesehatan Masyarakat, 15(2), 147–152. https://doi.org/https://doi.org/10.15294/kemas.v15i2.14349.
Specogna, A. V., Turin, T. C., Patten, S. B., & Hill, M. D. (2017). Hospital treatment costs and length of stay associated with hypertension and multimorbidity after hemorrhagic stroke. BMC Neurology, 17(158). https://doi.org/https://doi.org/10.1186/s12883-017-0930-2.
Suiraoka, I. P. (2012). Penyakit Degeneratif; Mengenal, Mencegah dan Mengurangi Faktor Resiko 9 Penyakit Degeneratif. Nuha Medika.
Yang, F., Zhao, J., & Xu, H. (2017). Characteristics of Hemorrhagic Stroke following Spine and Joint Surgeries. BioMed Research International, 2017(1), 1–6. https://doi.org/10.1155/2017/5390839
- The authors agree to transfer the transfer copyright of the article to The Indonesian Journal of Public Health effective if and when the paper is accepted for publication.
- Authors and other parties are bound to the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License for the published articles, legal formal aspect of journal publication accessibility refers to Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License (CC BY-NC-SA), implies that:
- Attribution ” You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- NonCommercial ” You may not use the material for commercial purposes.
- ShareAlike ” If you remix, transform, or build upon the material, you must distribute your contributions under the same license as the original.
